Trial Profile
Comparison of insulin glargine vs standard insulin therapy [bedtime insulin suspension isophane] in CFRD [cystic fibrosis-related diabetes] without fasting hyperglycemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 27 Aug 2007 The expected completion date for this trial is now 1 Aug 2005.
- 19 Sep 2006 New trial record.